GridAI Technologies (GRDX) Total Non-Current Liabilities (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Total Non-Current Liabilities came in at $18.0 million in Q2 2026, up 33.76% quarter-over-quarter from $13.5 million in Q4 2025.
Powered by 
Analysis
GridAI Technologies (GRDX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Total Non-Current Liabilities for 9 consecutive years, with $18.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities changed N/A year-over-year to $18.0 million; the trailing twelve-month figure through Jun 2026 stood at $18.0 million (changed N/A YoY), and the FY2025 full-year result was $13.5 million, changed N/A from the prior year.
- Total Non-Current Liabilities advanced to $18.0 million in Q2 2026 per GRDX's latest filing, from $13.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $38.5 million in Q3 2025 and bottomed at $13.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 81.11 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 36.04 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 5.92 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 7.74 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 40.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 3.92 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 12.42 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 378.37 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 18.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.02 Mn |
| Dec 31, 2025 | 13.47 Mn |
| Sep 30, 2025 | 38.52 Mn |
| Dec 31, 2021 | 12.30 Mn |
| Sep 30, 2021 | 19.10 Mn |
| Jun 30, 2021 | 6.45 Mn |
| Mar 31, 2021 | 3.57 Mn |
| Dec 31, 2020 | 15.55 Mn |
| Sep 30, 2020 | 2.63 Mn |
| Jun 30, 2020 | 7.62 Mn |
| Dec 31, 2019 | 4.29 Mn |
| Sep 30, 2019 | 5.82 Mn |
| Jun 30, 2019 | 6.22 Mn |
| Mar 31, 2019 | 5.76 Mn |
| Dec 31, 2018 | 3.00 Mn |
| Sep 30, 2018 | 1.47 Mn |
| Jun 30, 2018 | 2.61 Mn |
| Mar 31, 2018 | 2.82 Mn |
| Dec 31, 2017 | 2.48 Mn |
| Sep 30, 2017 | 2.73 Mn |